Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 13:15:e68.
doi: 10.15420/ecr.2020.04. eCollection 2020 Feb.

Factors Related to Maternal Adverse Outcomes in Pregnant Women with Cardiac Disease in Low-resource Settings

Philippe Amubuomombe Poli  1 , Elkanah Omenge Orang'o  1 , Ann Mwangi  2 , Felix Ayub Barasa  3
Affiliations
Review

Factors Related to Maternal Adverse Outcomes in Pregnant Women with Cardiac Disease in Low-resource Settings

Philippe Amubuomombe Poli et al. Eur Cardiol. .

Abstract

Background: Cardiac disease is an important life-threatening complication during pregnancy. It is frequently seen in pregnant women living in resource-limited areas and often results in premature death. Aim: The aim of this hospital-based longitudinal study was to identify factors related to adverse maternal and neonatal outcomes in pregnant women with cardiac disease in low-resource settings. Methods: The study enrolled 91 pregnant women with congenital or acquired cardiac disease over a period of 2 years in Kenya. Results: Maternal and early neonatal deaths occurred in 12.2% and 12.6% of cases, respectively. The risk of adverse outcomes was significantly increased in those with pulmonary oedema (OR 11, 95% CI [2.3.52]; p=0.002) and arrhythmias (OR 16.9, 95% CI [2.5.113]; p=0.004). Limited access to care was significantly associated with adverse maternal outcomes (p≤0.001). Conclusion: Many factors contribute to adverse maternal and neonatal outcomes in pregnant women with cardiac disease. Access to comprehensive specialised care may help reduce cardiac-related complications during pregnancy.

Keywords: Adverse outcomes; cardiac disease and pregnancy; cardiac events; obstetric events; resource-limited settings; therapeutic abortion.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Maternal Adverse Cardiac Outcomes
Figure 2:
Figure 2:. Maternal Adverse Obstetric Outcomes
See this image and copyright information in PMC

References

    1. Ashrafi R, Curtis SL. Heart disease and pregnancy. Cardiol Ther. 2017;6:157–73. doi: 10.1007/s40119-017-0096-4. - DOI - PMC - PubMed
    1. Ertekin E, Van Hagen IM, Salam AM et al. Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC, a registry from the European Society of Cardiology. Int J Cardiol. 2016;220:131–6. doi: 10.1016/j.ijcard.2016.06.061. - DOI - PubMed
    1. Diao M, Kane A, Ndiaye MB et al. Pregnancy in women with heart disease in sub-Saharan Africa. Arch Cardiovasc Dis. 2011;104:370–4. doi: 10.1016/j.acvd.2011.04.001. - DOI - PubMed
    1. Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27:89–94. doi: 10.5830/CVJA-2016-021. - DOI - PMC - PubMed
    1. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the Task Force for the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:3165–241. doi: 10.1093/eurheartj/ehy340. - DOI - PubMed

LinkOut - more resources